The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Improving neoadjuvant chemoradiotherapy for rectal cancer with CRLX101, a nanoparticle-drug conjugate, with a camptothecin payload.
 
Andrew Wang
No Relationships to Disclose
 
Xi Tian
No Relationships to Disclose
 
Minh Nguyen
No Relationships to Disclose
 
Autumn Jackson McRee
No Relationships to Disclose
 
Hanna Kelly Sanoff
No Relationships to Disclose
 
Bert H. O'Neil
Consulting or Advisory Role - Acceleron Pharma; Amgen; Genentech/Roche; Sanofi
Speakers' Bureau - Amgen
Research Funding - Novartis (Inst)
 
Meliessa G. Hennessy
Employment - Cerulean Pharma
Leadership - Cerulean Pharma
Stock and Other Ownership Interests - Cerulean Pharma
 
Scott Eliasof
Employment - Cerulean Pharma
Leadership - Cerulean Pharma
Stock and Other Ownership Interests - Cerulean Pharma
Research Funding - Cerulean Pharma
Patents, Royalties, Other Intellectual Property - Cerulean Pharma
Travel, Accommodations, Expenses - Cerulean Pharma
 
Edward Graeme Garmey
Employment - Cerulean Pharma
Leadership - Cerulean Pharma
Stock and Other Ownership Interests - Cerulean Pharma
Research Funding - Cerulean Pharma
Patents, Royalties, Other Intellectual Property - Cerulean Pharma
Travel, Accommodations, Expenses - Cerulean Pharma
 
Joel E. Tepper
No Relationships to Disclose